US · Healthcare

Inovio Pharmaceuticals Inc (INO)

Biotechnology

Inovio Pharmaceuticals Inc (INO) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for INO

P/E ratio

25.00

Inovio Pharmaceuticals Inc (INO) — FAQ

What is INO's P/E ratio?

The price-to-earnings (P/E) ratio for Inovio Pharmaceuticals Inc (INO) is 25.00 (data as of 2026-05-23).

Does Inovio Pharmaceuticals Inc pay a dividend?

Dividend yield is not available in the current snapshot for Inovio Pharmaceuticals Inc (INO). Check the MyAverix Finance app for the latest dividend data.

What sector is Inovio Pharmaceuticals Inc in?

Inovio Pharmaceuticals Inc (INO) is classified in the Healthcare sector (Biotechnology industry).

What exchange is INO listed on?

INO is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)